Skip to main content
Jeffrey Lebensburger, DO, Pediatric Hematology & Oncology, Birmingham, AL, Children's of Alabama

JeffreyDavidLebensburgerDOMSPH

Pediatric Hematology & Oncology Birmingham, AL

Professor, Pediatrics, University of Alabama at Birmingham School of Medicine

Dr. Lebensburger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lebensburger's full profile

Already have an account?

Summary

  • Dr Lebensburger is a board certified Pediatric Hematologist Oncologist. He specializes in Hematology with national expertise in SCD Nephropathy

Education & Training

  • University of Tennessee
    University of TennesseeFellowship, Pediatric Hematology/Oncology, 2006 - 2009
  • Orlando Health/Arnold Palmer Hospital for Children
    Orlando Health/Arnold Palmer Hospital for ChildrenResidency, Pediatrics, 2003 - 2006
  • Nova Southeastern University College of Osteopathic Medicine
    Nova Southeastern University College of Osteopathic MedicineClass of 2003

Certifications & Licensure

  • AL State Medical License
    AL State License 2009 - 2024
  • WI State Medical License
    WI State License 2014 - 2014
  • TN State Medical License
    TN State License 2006 - 2009
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Scholar Award American Society of Hematology
  • Best Doctors in America Best Doctors

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Impact of Hyperfiltration during Early Childhood on the Natural History of Albuminuria in Pediatric Sickle Cell Anemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Authored Content

  • Outcomes in Mild to Moderate Isolated ThrombocytopeniaJuly 2018

Press Mentions

  • Priapism in Sickle Cell Disease: Associations Between NOS3 and EDN1 Genetic Polymorphisms and Laboratory Biomarkers
    Priapism in Sickle Cell Disease: Associations Between NOS3 and EDN1 Genetic Polymorphisms and Laboratory BiomarkersFebruary 4th, 2021
  • Marijuana Use and Health Behaviors in a US Clinic Sample of Patients with Sickle Cell Disease
    Marijuana Use and Health Behaviors in a US Clinic Sample of Patients with Sickle Cell DiseaseJuly 14th, 2020
  • UAB - School of Medicine - Pediatrics
    UAB - School of Medicine - PediatricsJune 25th, 2017

Grant Support

  • Chronobiology and Chronopharmacology to Prevent Sickle NephropathyNational Heart Lung Blood Institute2015–2019
  • Scholar AwardAmerican Society of Hematology2015–2018
  • Sickle Cell Aspire GrantPfizerPresent

Hospital Affiliations